Large differences between patients with acute myocardial infarction included in two Swedish health registers

Sara Aspberg1, Ulf Stenestrand, Max Köster

  • 1Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. sara.aspberg@ds.se

Insights

This study compared two Swedish registries for acute myocardial infarction (MI). The Register of information and knowledge about Swedish heart intensive care admissions (RIKS-HIA) captured healthier patients, while the Swedish statistics of acute myocardial infarctions (S-AMI) had broader coverage but less detail.

Area of Science:

  • Cardiology
  • Public Health
  • Health Informatics

Background:

  • Acute myocardial infarction (MI) is a significant cause of illness and death in Sweden.
  • Effective patient data management is crucial for improving cardiovascular care.
  • Two major Swedish registries, RIKS-HIA and S-AMI, capture data on acute MI patients.

Purpose of the Study:

  • To compare the characteristics of acute MI patients registered in RIKS-HIA versus S-AMI.
  • To assess the coverage and representativeness of these two national health registries.
  • To inform strategies for enhancing the quality of care for acute coronary syndromes.

Main Methods:

  • A population-based register study utilizing data from RIKS-HIA, S-AMI, the National patient register, and the Cause of death register.
  • Logistic regression analysis was employed to determine odds ratios.
  • Data linkage was performed for cases between 2001 and 2007.

Main Results:

  • Over 114,000 cases were in RIKS-HIA and nearly 200,000 in S-AMI.
  • Linked data included over 110,000 cases, revealing RIKS-HIA patients were younger, more often male, healthier, and received more invasive procedures.
  • Significant regional variations existed in patient reporting to RIKS-HIA.

Conclusions:

  • RIKS-HIA included approximately half of all acute MI patients, representing a healthier subgroup.
  • S-AMI captured nearly all acute MI cases but offered limited patient information.
  • Combining both registries can improve the quality of care for all acute coronary syndrome patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...